Medica Companies Portfolio20 · MEDICA 2010 Israel inspired by innovation The Israel Export & International Cooperation Institute. 2 Israel: Life Science Powerhouse Israeli physicians,

This publication is for informational purposes only. While every effort has been made to ensure that the information is correct, The IsraelExport & International Cooperation Institute assumes no responsibility for damages, financial or otherwise, caused by the information herein.© September 2010 The Israel Export & International Cooperation Institute | Production: IEICI Media & Production Division | Editing: Joseph Alexander Design: Graphic Touch

Hall 16 - G28, G37, G40 | Hall 5 - M19 | Hall 3 - E44November 17-20 | Düsseldorf, Germany

Israel atMEDICA 2010

Israelinspired by innovation

The Israel Export & International Cooperation Institute

2

Israel: Life Science Powerhouse Israeli physicians, scientists, researchers and engineers have propelled the country's Medical Device industry to the leading edge of innovation and creativity, spanning all fields of medicine. Quick facts: • Israel is considered to be the second largest supplier of Medical Device solutions worldwide. • Israel ranks #1 in Medical Device patents per capita (#4 in absolute figures). • There are over 1,100 life science companies in Israel; 65% of them are Medical Device firms. Several global medical corporations have found Israeli companies to be attractive business partners. Israeli companies have proven their excellence in R&D, and in implementing breakthrough technologies in the Medical Device industry. Some of the leading multinationals holding equity positions in Israel include GE Medical, Philips, Siemens, Boston Scientific, Johnson & Johnson, and Medtronic. A strong entrepreneurial spirit pervades Israeli society. Perhaps fueled by a young country’s need to develop creative solutions quickly and cost-effectively, or inspired by improvisation and calculated risk-taking, it seems that innovation is an Israeli way of life.

• Israel’s 16 Technology Transfer Organizations (TTOs) showcase the creative fusion between universities, hospital systems, businesses and the military. All of the TTOs are dedicated to encouraging and promoting research projects and military technology from the lab to the world market.

• Healthcare is a priority in a well-educated country. Israel spends 8% of its GDP on healthcare. It boasts a very high level of healthcare and an extensive infrastructure of quality resources that range from local community clinics to world-renowned trauma centers. The country has a high ratio of MDs to population (3.5 per 1,000). The country’s entrepreneurial spirit runs through this sector as well: Many Israeli physicians are both early adopters of new technologies and developers of original technologies in their own right.

• Israel has a highly skilled workforce. The country has the greatest number of scientists and engineers per capita in the world; 24% of the workforce have academic degrees.

• The defense community nurtures the life science industry. Extensive investment in developing state-of-the-art technologies for defense has proved fertile ground for advanced life science applications. Two very well-known innovations emerged from Rafael Advanced Defense Systems: PillCamTM, a video capsule endoscope (developed by Given Imaging), and cryotherapy for the treatment of cancer (developed by Galil Medical).

• Strong institutional incentives support the development of new technologies. The 23 government-licensed technological incubators, which began in the 1990s as a way to provide employment opportunities for new immigrant scientists and engineers (many from the former Soviet Union), has evolved as a successful framework for advancing and commercializing early-stage life science technologies. In fact, in 2008, approximately 38% of the 1,175 incubator graduate companies continued beyond the incubator stage to function as mature companies.

Nearly half of Israel’s technological incubators focus on the life sciences or biotechnology. At the end of 2008, 41% of all incubated companies were involved in medical devices, and 18% in biotechnology. Of the $360 million in grant money awarded to incubator companies by Israel’s Office of the Chief Scientist in 2008, 25.4% went to those involved in the life sciences.

• The world’s venture capital community keeps its focus on Israel. In 2008, about 80 Israeli and international VC companies targeted specific investment efforts on Israel. Of these, nine are focused solely on life sciences.

For more information:

Ms. Angelica Khachaturov, Business Development Manger – Medical Device & Healthcare IT, Israel Export & International Cooperation Institute | Tel: +972-3-514-2986 | Fax: +972-3-514-2881 | [email protected]

3

The Israel Export & International Cooperation Institute (IEICI) The Israel Export & International Cooperation Institute, supported by member firms, private sector bodies and the government of Israel, advances business relationships between Israeli exporters and overseas businesses and organizations. By providing a wide range of export-oriented services to Israeli companies and complementary services to the international business community, the Institute helps build successful joint ventures, strategic alliances and trade partnerships.

The IEICI’s Life Science Department is the leader in business matching between the more than 1,200 companies in the Israeli life science industry and worldwide business partners at all levels. It has a proven ability to identify and match suitable potential business partners, organize one-on-one business meetings, and is a focal point for contacts with the government as well as with industry. The IEICI is the major organizer of Israeli company participation at Medica 2010. Visit the IEICI at Medica, Hall 16 Booth G40. www.export.gov.il/ls

Foreign Trade Administration Ministry of Industry, Trade and Labor The Foreign Trade Administration of the Ministry of Industry, Trade and Labor manages and directs the State of Israel’s international trade policy. The Administration's main fields of activity include activities for the promotion of international trade and exports, negotiating and maintaining trade agreements for improving Israel’s trade network, attracting and encouraging foreign investments, and creating strategic alliances with foreign companies. In addition to its activities in Israel, the Administration operates a network of economic representatives, who act as the ministry’s operational arm in markets abroad. Objectives: • Assisting Israeli industry in deepening its activities in existing markets and penetrating new markets. • Accompanying and supporting individual exporters in their marketing activity abroad. • Negotiating and implementing international trade agreements, and maintaining existing agreements. • Promoting investments and strategic partnerships. • Promoting the image of the Israeli industry and economy abroad.

For more information, visit www.trade.gov.il

Table of Contents Medical Device Companies Index Aesthetics and Dermatology • Cnoga………………………………………………………………………………………………………... 16 • CoolSense Medical………………………………………………………………………………………… 18 • Erika Carmel………………………………………………………………………………………………… 23 • TavTech……………………………………………………………………………………………………… 49 Cardiovascular and Peripheral Vascular • BSP Biological Signal Processing………………………………………………………………………... 14 • C-Boot……………………………………………………………………………………………………….. 15 • Flexicath……………………………………………………………………………………………………... 26 • HypnoCore…………………………………………………………………………………………………... 30 • Itamar Medical……………………………………………………………………………………………… 32 • VitalCare Medical…………………………………………………………………………………………... 50 Diagnostics • 3QBD………………………………………………………………………………………………………… 8 • BSP Biological Signal Processing………………………………………………………………………... 14 • Cnoga………………………………………………………………………………………………………... 16 • Common Sense……………………………………………………………………………………………... 17 • Elitr Advanced Systems……………………………………………………………………………………. 20 • Elsmed Medical Systems…………………………………………………………………………………... 22 • Hypnocore…………………………………………………………………………………………………... 30 • Itamar Medical……………………………………………………………………………………………… 32 • Medoc………………………………………………………………………………………………………... 35 • Sialo Technologies………………………………………………………………………………………… 44 • SPO Medical Technologies………………………………………………………………………………... 47 • VitalCare Medical…………………………………………………………………………………………... 50 Disposable and Implantable • Albaad……………………………………………………………………………………………………….. 10 • ETView……………………………………………………………………………………………………….. 24 • First Care Products………………………………………………………………………………………… 25 • Flexicath……………………………………………………………………………………………………... 26 • Hanita Lenses……………………………………………………………………………………………….. 29 • Intromedix…………………………………………………………………………………………………... 31 • Mizra Medical……………………………………………………………………………………………….. 36 • Sion Biotext Medical……………………………………………………………………………………….. 46 Endoscopes and Accessories • Orpheus……………………………………………………………………………………………………... 39 • Sialo Technologies………………………………………………………………………………………… 44

5

E.M.S. • Beth-El Zikhron Yaaqov Industries……………………………………………………………………… 12 • ETView……………………………………………………………………………………………………….. 24 • First Care Products………………………………………………………………………………………… 25 • Flight Medical……………………………………………………………………………………………….. 27 Gynecology and Women’s Health • 3QBD………………………………………………………………………………………………………… 8 • ACU Medical Technologies………………………………………………………………………………... 9 • Artisan Sonics………………………………………………………………………………………………. 11 • Common Sense……………………………………………………………………………………………... 17 • Elmedical…………………………………………………………………………………………………….. 21 Hospital Equipment • Beth-El Zikhron Yaaqov Industries ……………………………………………………………………… 12 • Coolsense Medical………………………………………………………………………………………… 18 • EarlySense…………………………………………………………………………………………………... 19 • Elsmed Medical Systems…………………………………………………………………………………... 22 • ETView……………………………………………………………………………………………………….. 24 • Flight Medical……………………………………………………………………………………………….. 27 • Haldor Advanced Technologies………………………………………………………………………….. 28 • Intromedix…………………………………………………………………………………………………... 31 • NanoVibronix……………………………………………………………………………………………….. 37 • OHK Medical Devices………………………………………………………………………………………. 38 • Pegasus Medical Concepts……………………………………………………………………………….. 40 • Polytex Technologies……………………………………………………………………………………… 41 • Q-Core Medical…………………………………………………………………………………………….. 42 • Shekel Scales………………………………………………………………………………………………... 43 • SPO Medical Systems……………………………………………………………………………………… 47 Infection Control and Infectious Diseases • Albaad………………………………………………………………………………………………………... 10 • Beth-El Zikhron Yaaqov Industries………………………………………………………………………. 12 • Mizra Medical……………………………………………………………………………………………….. 36 • NanoVibronix………………………………………………………………………………………………. 37 • Sion Biotext Medical……………………………………………………………………………………….. 46 Industrial OEM • Albaad………………………………………………………………………………………………………... 10 • B.R.F. Engineering…………………………………………………………………………………………... 13 • Shekel Scales………………………………………………………………………………………………... 43 Ophthalmology • Hanita Lenses ………………………………………………………………………………………………. 23 • Sion Biotext Medical……………………………………………………………………………………….. 26 • Talshir Medical Technologies…………………………………………………………………………….. 48

6

Orthopedic • Erika Carmel ………………………………………………………………………………………………… 23 • Flexicath…………………………………………………………………………………………………….. 26 • Meditouch…………………………………………………………………………………………………… 34 • OHK Medical Devices……………………………………………………………………………………..... 38 • Sion Biotext Medical………………………………………………………………………………………. 46 Respiratory and Pulmonary • ETView……………………………………………………………………………………………………….. 24 • Flight Medical………………………………………………………………………………………………. 27 • Hypnocore…………………………………………………………………………………………………... 30 • Itamar Medical……………………………………………………………………………………………… 32 Services • 2P2D Solutions…………………………………………………………………………………………….. 7 • B.R.F. Engineering…………………………………………………………………………………………... 13 • Medical Market Bridge……………………………………………………………………………………. 33 • Signal Business Development……………………………………………………………………………. 45 Telemedicine and Healthcare IT • 2P2D Solutions……………………………………………………………………………………………... 7 • Artisan Sonix………………………………………………………………………………………………... 11 • Elitr Advanced Systems……………………………………………………………………………………. 20 • Hypnocore…………………………………………………………………………………………………... 30 • Meditouch………………………………………………………………………………………………….... 34 • Orpheus……………………………………………………………………………………………………… 39 • Shekel Scales………………………………………………………………………………………………... 43 Urology • Elmedical…………………………………………………………………………………………………….. 21 • Mizra Medical……………………………………………………………………………………………….. 36 • NanoVibronix……………………………………………………………………………………………….. 37 Wound Management and Pain Management • C-Boot……………………………………………………………………………………………………….. 15 • Erika Carmel………………………………………………………………………………………………… 23 • Medoc………………………………………………………………………………………………………... 35 • NanoVibronix……………………………………………………………………………………………….. 37 • Sion Biotext Medical……………………………………………………………………………………….. 46

7

2P2D Solutions Ltd. Back to TOC

www.2p2d.com

Company at a Glance

2P2D Solutions Ltd. is a pioneering technology-based company developing unique solutions for various unmet needs within the healthcare, biotech and pharmaceutical industries. 2P2D Solutions Ltd. has developed a breakthrough automated drug monitoring system for use in clinical drug trials that incorporates a portable, personalized medication dispensing device using proprietary 2P2D technology.

Category, Subcategory & Therapeutic Area(s)

Category: Medical Devices, Healthcare IT

Subcategory: Telemedicine, Medication Management, Services, CRO

Therapeutic Area(s):

Company Status: R&D, Proof of Concept

Technology & Product(s)

• 2P2D Solutions Ltd. has developed ClinicAid, a breakthrough automated drug monitoring system that incorporates a portable medication dispensing device using proprietary 2P2D technology. The system dispenses personalized drug dosages designated for each specific patient or group of patients. For safety reasons, the drug is dispensed only after patient identification has been fully authenticated, and according to the designated clinical trial treatment regimen. This exclusive medication management system, for use in clinical drug trials, ensures unequaled compliance, accountability and accuracy.

• The Company’s telemedicine solution provides: • Complete and real-time knowledge of the participant’s compliance and adherence to the trial protocols. • Reduced overall duration of the clinical trial period. • Increased participant compliance and adherence to the given medication.

• Cost effective solution for clinical trial packaging and drug accountability.

Goal

Objectives: Investment, Strategic Alliances

Target Businesses: CROs, pharma companies,hospitals

Target Countries: Worldwide

8

3QBD Back to TOC

www.3qbd.com

Company at a Glance

Located in Arad, Israel, 3QBD Ltd. is an ISO certified startup medical device company. The company has developed the VGTest, a gynecological diagnostic device based on Ion Mobility Spectrometry (IMS) which is used in the detection of vaginal infections.

In December 2009, 3QBD Ltd. received the European CE mark for the VGTest, a device capable of detecting and returning a positive/negative result for Bacterial Vaginosis, the most prevalent women’s vaginal infection, within 60 seconds.

Future development plans for 3QBD include expanding research further into the medical field, to detect additional major infections and diseases and offer rapid, accurate results. Other applications for the technology include cancer, food and livestock.


Category: Medical Devices

Subcategory: Diagnostics

Therapeutic Area(s): Gynecology, Obstetrics, Women's Health

Company Status: Clinical Trials, Regulatory Approval


IMS (Ion Mobility Spectrometry) Technology

3QBD's technology is based on the well-established and scientifically proven Ion Mobility Spectrometry (IMS) technology – first used successfully to detect drugs and explosives. Today IMS is being used to detect presence and type of infection.

Chemical changes in living systems, or degradation of cells after death through enzymatic and microbial processes, are accompanied by the breakdown of amino acids and production of biogenic amines. Pathological conditions in the human body may be expressed in the formation of biogenic amines, so that elevated levels of biogenic amines may be indicative of dysfunctions. IMS is a sensitive instrumental technique for detecting volatile compounds. It is based on measuring the velocity of ions (ion mobility) drifting through a gas bath under the influence of an electric field.

The Product

The device works by measuring biogenic amines that are present at elevated levels in infections and diseases, and returns a rapid accurate result. In the case of Bacterial Vaginosis the result is provided within one minute. In addition, the VGTest for BV spares the physician from having to perform the Amsel Test and “whiff tests” of vaginal fluid, or spend time waiting for laboratory Gram Stain results.

Goal

Objectives: Distribution, R&D Funding

Target Businesses: Women’s health professionals, gynecologists, obstetricians, hospitals and health clinics


9

ACU Medical Technologies Israel Back to TOC

www.easylabour.com

Company at a Glance

ACU Medical Technologies develops and markets the patent-protected EasyLabour® device to bring comfort to women giving birth. EasyLabour is a non-invasive, drug-free way to alleviate labour pain by conveniently and comfortably applying pressure to specific acupressure points in the lower back. Launched after a successful clinical trial that demonstrated a dramatic decrease in labour pain, EasyLabour has been widely accepted and recommended by major medical centers and endorsed by obstetric professionals. ACU Medical Technologies is staffed by a team of seasoned experts in pain medicine, obstetrics, midwifery, medical device engineering, product design and electro-mechanical engineering.



Subcategory: Medical Equipment

Therapeutic Area(s): Obstetrics, Women's Health

Company Status: Initial Revenues


EasyLabour ® conveniently and comfortably applies acupressure to six specific acupressure points, three points on each side of the spine, on the sacral foramina of a woman during labour.A dedicated clinical trial to determine the level of pain relief experienced was conducted in the obstetrics department of a large medical center. The results indicated that continuous rotational pressure applied to the sacral area while using the self-operated electro-mechanical device was found to significantly reduce labour pain within five minutes. Preliminary indications also suggest a shorter pain period during a contraction while using EasyLabour. EasyLabour ® is a CE mark, Class I device. Several hospitals are now using EasyLabour ® worldwide as a complementary pain relief alternative.

Goal

Objectives: Find distribution channels, locate leading end-use customers

Target Businesses: Hospitals (private and public), private obstetric clinics, independent professionals involved in obstetrics


10

ALBAAD Back to TOC

www.albaad.com www.albaad.com/generalPage.aspx?pageID=Pharma

Company at a Glance

Albaad is one of the three leading producers of wipes worldwide. As a fully integrated converter owning production facilities in Germany, the US and Israel, global R&D, regulatory and production teams, Albaad is a preferred partner for numerous renowned multinationals and retailers. We don’t just make wet wipes; we make it our business to know everything there is to know about them, constantly studying customer needs, market trends and technological innovations.



Subcategory: Disposable, Industrial OEM, Accessories

Therapeutic Area(s): General Health, Infection Control



Albaad has invested in the development and registration of a range of products intended for professional and consumer healthcare use. Our products are registered as medical device class 2a, FDA and EPA where applicable. Albaad will have been accredited ISO 13485 medical standard for its pharma production lines by the end of 2010. The range includes several surface and medical device disinfectants, hand hygiene, patient care and bathing kits, adult incontinence wipes and several consumer solutions, including natural fever relief, jellyfish relief, hemorrhoids relief and antiseptic wipes. Albaad wipes are one-step ready for use wipes, tailored to meet our customers’ special needs and requirements. They are made with soft fabrics and impregnated with gentle yet effective liquids. The wipes are produced and tested according to stringent standards and inspected by strict quality assurance procedures.

Goal

Objectives: Seeking strategic partners to leverage R&D, regulatory and production capabilities for

development and sales to professional, institutional and consumer healthcare

markets in Europe and worldwide.

Target Businesses: Professional, institutional and consumer healthcare

Target Countries: EU, Worldwide

11

Artisan Sonics Ltd. Back to TOC

www.artisansonics.com/Eng

Company at a Glance

Artisan Sonics is an Israeli software house serving the medical community in Israel since 1996. Our customers include Hospitals, Public Health Providers and Private Clinics. We specialize in streamlining the work of OB&GYN ultrasound (US) practitioners and their supporting staff, where our distinct leadership is well established. The streamlining concept is implemented through continuous fieldwork and close collaboration with doctors and other medical personnel. Identified needs transform into applications that solve the needs, thus streamlining the working environment, saving time and money. Our innovative solutions are engineered to enhance care quality, reduce risk, assure compliance and overall to improve the quality of clinical management. Essentially, these features provide a positive health outcome for our customers' patients. The aforesaid results are achieved by a strict commitment to maintaining the highest standards of quality. Artisan Sonics is led by Dr. Yoram Alperovitch, who has an extensive background in medical devices and IT applications. Dr. Alperovitch is supported by a steering committee whose members are world-renowned practitioners in the area of OB&GYN ultrasound.



Subcategory: Diagnostic, PACS Archiving, Internet-based Health Information

Therapeutic Area(s): Obstetrics, Women's Health

Company Status: Revenue Growth


(a) Archiver – The Archiver is our flagship product. It allows the OB&GYN ultrasound (US) practitioner to save long video recordings of images, to transfer measurements from the US, to print reports of different exams while using a US machine for obstetric or gynecological scans. It shortens the reporting and documentation process by 25 to 45 percent. This extensive software is based on a dot.net and C++ client. (b) Pregnancy Supervision Package (PSP) – A Web application based on Linux and PHP allowing its users to perform pregnancy supervision. Data from the Archiver is automatically integrated into the PSP. (c) Visit Scheduling – A Web application allowing the scheduling of visits and appointments. The list of daily scheduled patients is automatically transferred into the Archiver. (d) Billing – A Web application to allow automatic generation of visit/exam bills. The scheduled visit exam type and patient details are automatically incorporated into the bill. (e) Remote Facility Exams Archiving – C++ client and IPVPN and Web technology for exams data dual storage in two separate locations; The backed up exams can be viewed through the Internet.

Goal

Objectives: To find agents and distributors

Target Businesses: Medical equipment representatives and resellers.

Target Countries: Europe and Asia

12

Beth-El Zikhron Yaaqov Industries Back to TOC

www.BEInd.com

Company at a Glance

Beth-El Zikhron Yaaqov Industries Ltd. is a leading developer and manufacturer of Medical Negative Pressure Isolation Systems and Collective NBC Filtration Systems. Drawing on more than 30 years of experience in the air filtration field, Beth El Industries now offers the medical market an array of stationary and portable isolation chambers, clean/sterile rooms and stand-alone air filtration systems for various applications in hospitals and ground or airborne ambulances. Our isolation chambers series – IsoArk® – is designed to quarantine infected people and protect the atmosphere outside the chamber from contagious diseases like SARS, Ebola and TB. The main advantages of these devices are: • Allow for a quick and effective isolation • Simple and fast assembly that requires no additional tools • Completely portable (solution can be brought to the problem) • Come in a variety of sizes and can be custom made according to our client’s requests • Cost only a fraction of the price of a permanent stationary isolation room Certifications: Beth-El Zikhron Yaaqov Industries Ltd. is certified for ISO 9001:2000, AQAP-2110 and AS 9100 quality management systems, and is audited regularly by external entities.




Therapeutic Area(s): Emergency Medicine, General Surgery, Infection Control, Infectious Diseases, Veterinary



• IsoArk - portable, negative pressure chamber designed for a rapid set up of a biologically isolated environment, for quick and effective isolation of contagious people and equipment. The system includes an airlock attached to the main chamber and an air filtration system. Special features of this system enable treating the patient from the outside, avoiding contamination of equipment and staff. All of the system components meet and exceed today’s standards for airborne infection isolation, including the CDC guidelines for healthcare control.

• IsoArk N36-2 - portable chamber designed for transporting a single person under isolated conditions. IsoArk N36-2 fits on any standard stretcher, and is ideally suited for use in ground and airborne ambulances. IsoArk N36-2 is equipped with its own negative pressure filtration system, an “all around” zipper and integrated gloves and utility portals. With the battery fully charged, the system can operate for up to 10 hours independently of an external power source and guarantees a complete isolation of the space inside the chamber during transport. The “collapsible,” lightweight structure allows for a quick set up of the system and minimal storage requirements when not in use.

Goal

Objectives: 1. Agent, able to promote the products to the medical and emergency preparedness sectors in his country. 2. Contact with potential end customers

Target Businesses: Government agencies in charge of emergency prepardness, hospitals, importers and distributors, health ministry, ambulance and ambulance equipment companies, airports.


13

B.R.F. Engineering Ltd. Back to TOC

www.brf-eng.com Company at a Glance

B.R.F. is a hi-tech company based in Nazareth Illit, Israel. It is a leading provider of comprehensive end-to-end integrated outsourcing solutions for OEMs. B.R.F. designs, develops and manufactures complete packaged products and provides after-market services for its OEM customers. B.R.F. offers its innovative and integrated technologies of design, development and manufacturing supporting the company’s professional and social vision principles: • Facilitating and improving the customer's level of operations. • Lowering design and development costs. • Lowering production costs. • Reducing time to market (TTM). • Social responsibility. • Obtain, protect and leverage intellectual property rights to our designs.


Category: Services

Subcategory: Subcontractor, OEM, Robotics, Medical Equipment, Research Equipment




• Machine design for the high-tech, bio-tech, microelectronics and food industries. • Electronic packaging design, starting from the initial setting, production file and product prototype. • Industrial machine design. • Mechanical guidance and backup ending with current production in short timetables. • Finite Elements Manufacturing Analysis (FEA). • Computer aided design services (CAD). • Technical writing (user manual including operational methods, assembly process and test procedures),

and brochures. • In-house production.

Goal

Objectives: Medical OEMs

Target Businesses: Medical OEMs

Target Countries: Europe and America

14

BSP Biological Signal Processing Ltd. Back to TOC

www.bspmedical.com

Company at a Glance

Founded in 2000, BSP Biological Signal Processing Ltd. is a medical device company with corporate offices in Tel Aviv, Israel and a US subsidiary – BSP, Inc. – with sales and marketing offices in Rockville Maryland, US. BSP is publicly traded on the Tel Aviv Stock Exchange since 2006 (TASE:BSP). BSP develops and commercializes a new generation of systems for non invasive diagnosis and monitoring of Ischemic Heart Disease (IHD), based on advanced signal processing of the ECG signal which integrates the Company’s unique, patented, HyperQ technology.



Subcategory: Diagnostics

Therapeutic Area(s): Cardiovascular



BSP has pioneered the clinical implementation of high-frequency ECG and has developed it into a fast, accurate, low-cost, simple to operate and non-radiating technology for detecting IHD with greater clinical value than the current standard ECG. The company’s proprietary HyperQ™ technology extracts and analyses the high-frequency components of the ECG and provides a unique diagnostic index. Thousands of patients have been tested with the HyperQ system to date, demonstrating consistently that HyperQ is far superior to conventional ECG both in sensitivity and specificity, with the potential to save up to 50% of the unnecessary radioactive imaging procedures, while improving the standard of care. BSP’s intellectual property portfolio is backed by four granted patents and 14 filed applications in different stages. HyperQ EX-300 Stress System: The HyperQ EX-300 Stress system enables an accurate and risk-free procedure for the early diagnosis of Ischemic Heart Disease (IHD). HyperQ stress testing is performed in a similar manner to a standard clinical stress test, providing the conventional stress ECG results, and the HyperQ test results, with extraordinary clinical accuracy. The system is offered as a combination of software and hardware that connects to a treadmill or stationary bicycle and constitutes a full ergometry (stress ECG) station that is FDA (510k) cleared and CE certified.

Goal

Objectives: The company’s primary strategic objectives include establishing HyperQ as the first line modality for monitoring and diagnosis of Ischemic Heart Disease in cardiology clinics, ambulatory and hospital settings, and attaining reimbursement code and premium coverage over competitors for the HyperQ diagnostic modality in the US. Growth in market penetration and market share will be achieved through a combination of business partnerships with equipment and healthcare service providers, and by the establishment of a global marketing and sales presence.

Target Businesses: Distributors specializing in cardiovascular diagnostic devices, leading manufacturers in the field of cardiovascular diagnostic devices for potential business partnerships, leading health service providers.


15

C-Boot Back to TOC

www.c-boot.com

Company at a Glance

C-Boot develops and manufactures advanced compression products for preventing and treating venous and lymphatic diseases and other conditions that require compression therapy, including DVT prevention.

C-Boot offers the first intermittent pneumatic compression (IPC) line of products powered automatically by energy generated from the patient’s body.

The company holds proprietary technological knowledge, patents covering the technological concept, and aspects in the field of low pressure compression.

The first line of product is already generating revenues through sales to distributors. The company is now focused on expanding its worldwide presence.

The manufacturing process is subject to stringent standards of quality assurance. All of C-Boot's products are FDA and CE approved, and the company has been granted the ISO 9001:2000 and ISO 13485:2003.




Therapeutic Area(s): Peripheral Vascular, Wound Care and Primary Care



C-Boot’s patented system is a wearable sleeve comprising a unique pneumatic brain and several inflatable chambers that wrap the leg. Using the body’s own kinetic energy while an individual is walking, the system inflates the chambers in a gradient and sequential cycle which leads to blood release from both the superficial and deep veins. This strengthens the body's natural tendency to enhance lymphatic and venous return, and enables the blood to re-circulate toward the heart.

C-Boot concept allows patients to maintain complete mobility without the need for cumbersome external pumps. The technology is protected by number of patents surrounding the use of kinetic energy to drive the pneumatic action, as well as the sophisticated internal mechanisms that allow for the pneumatic action to also be driven by a very small and portable compressor.

Goal

Objectives: Distribution, Alliances

Target Businesses: Clinics, home care, orthopaedics and rehabilitation centers

Target Countries: EU

16

Cnoga Medical Back to TOC

www.cnoga.com

Company at a Glance

Cnoga Medical is an innovative developer of easy-to-use, touch-free and non-invasive medical devices. Cnoga believes that the time is soon approaching when most blood tests will be conducted by the patients themselves, in the comfort of their own homes, and with a simple non-invasive device.



Subcategory: Monitoring

Therapeutic Area(s): Cardiovascular, Diabetics, Dermatology and Aesthetics, Hematology, Genetic Disorders, General Health



Cnoga Medical’s technology provides a new patent pending and state of the art solution for the non-invasive/touch-free methods of measuring physiological parameters. Cnoga's technology is based on real-time tissue photography. Tissue image color is processed in real-time, providing temporary color distribution, using dynamic range of at least 36 color-depth representing over 6.8^10 color combination. Then, by using a sophisticated mathematical algorithm, the vast amount of information is computed and analyzed for detecting the correlation between temporary color pigmentation and a specific bio or physiological parameter. Products: The Oximanometer – Pulse rate, blood pressure and SpO2 monitoring device The Hemoximeter – Hemoglobin, pulse rate, SpO2 monitoring device The Glucometer – Blood glucose, non-invasive, monitoring device

Goal

Objectives: Meet potential business partners and distributors, as well as potential customers

Target Businesses: Medical device distributors, hospitals and medical insurance companies

Target Countries: EU

17

Common Sense Ltd. Back to TOC

www.cs-commonsense.com

Company at a Glance

COMMON Sense’s proprietary technologies enable the diagnosis of bacterial vaginosis (BV), trichomoniasis and amniotic fluid leakage through the non-invasive collection of vaginal secretions on panty–liners as well as on vaginal swabs. COMMON SENSE carries out R&D, manufactures and markets non-invasive OTC panty-liner home tests and OTC and OTC/Rx professional vaginal swabs for gynecologists, point of care and hospitals for the: 1. Classification of common abnormal vaginal discharges and detection of acidity parameters associated

with BV or trichomoniasis in symptomatic women. VI-SENSE (VI=Vaginal Infections) panty-liner and swabs kit 2. Detection of amniotic fluid leakage. AL-SENSE (AL=Amniotic Leak) panty-liner kit 3. Monitoring pregnant women with pre-term delivery history for asymptomatic BV infection and reduce risk of pre-term delivery. VA–Sense (VA=Vaginal Acidity) panty-liner kit 4. Monitoring pH in asymptomatic women as an early warning for vaginal itching, odors and other symptoms. Norma-Sense panty- liner The company's inventions have been filed as US patents and PCT. The products are FDA and CE approved.



Subcategory: Diagnostic

Therapeutic Area(s): Gynecology, Women's Health



COMMON SENSE Ltd.'s proprietary technology includes a range of indicator polymers that react with different pH levels, buffer capacity values, and ammonium ion concentrations by changing color from yellow to blue green, in the presence of vaginal secretions with elevated pH levels that indicate BV or trichomoniasis or an amniotic fluid leak.The resulting stain is stable for many hours, while the change in color due to the contact with urine is reversible. These kits providee, for the first time, the revolutionary ability to determine non-invasively the cause of abnormal vaginal discharge, and to identify amniotic fluid leakage. The company believes this technology to be applicable to a host of novel applications that until now have had no solution.

Goal

Objectives: COMMON SENSE Ltd.'s goal is to become the leading supplier of home and professional tests for common abnormal discharges, monitoring for abnormal pH levels, and detection of amniotic fluid leakage, as well as for other gynecological and urological conditions

Target Businesses:


18

CoolSense Medical Ltd. Back to TOC

www.coolsense.net Company at a Glance

CoolSense Medical Ltd. is a subsidiary of the M.D. Clinic Group based in Tel Aviv, Israel; an established and prestigious medical health center whose specialty in non-surgical aesthetic procedures serves an extensive network of cosmetic treatment clinics. CoolSense Medical Ltd. was responsible for the R&D that preceded the manufacture of the innovative hand-held CoolSense™ pain numbing applicator. CoolSense's successfully implemented concept offers medical personnel, aestheticians and the general public a revolutionary but simply operated instrument that eliminates the pain and discomfort of injection procedures. The CoolSense™ Pain Numbing Applicator, which has received CE approval, FDA certification, and the Israeli Certificate of Free Sale is in use worldwide.




Therapeutic Area(s): Diabetics, Dermatology, Aesthetics, Endocrinology, General Health, Nephrology



The innovative CoolSense™ device, when applied to the skin immediately, anesthetizes the site of injection with no after effects. The CoolSense Pain-Free Injection Applicator has been accepted as an indispensable instrument for health care personnel when performing medical or cosmetic skin invasive procedures. The CoolSense™ Applicator is also an invaluable tool that greatly improves the quality of life for individuals who are obliged to undergo injection procedures on a daily basis. CoolSense™ acts within 3-5 seconds to do away with the stress and fear that is associated with receiving injections, the most common health-care procedure worldwide.

Goal

Objectives: Finding potential distributors for main European countries.

Target Businesses: Distributors

Target Countries: Germany, France, Switzerland, UK

19

EarlySense Ltd. Back to TOC

www.earlysense.com

Company at a Glance

EarlySense Ltd. is bringing to market the EverOn system, an automatic, continuous, contact-free patient monitoring system that accurately identifies high-risk patient conditions. Alerting caregivers immediately upon detecting such events enables earlier interventions, leading to reduced complications and costs. EarlySense is headquartered in Ramat Gan, Israel and employs a multi-disciplinary team of 25 engineers, physicists, physicians, nurses and marketing professionals working closely with clinical sites worldwide. The Company’s vision is that within 10 years, all acute, chronic and geriatric patients will be continuously safeguarded with such continuous monitoring solutions in home and hospital settings. EarlySense's EverOn system bridges the critical time gap between patient deterioration and clinician intervention. In light of the Joint Commission’s 2009 Patient Safety Goals for healthcare organizations, EarlySense's technology offers a timely solution for detecting changes in a patient’s condition, while also helping nurses focus on the patients who need their immediate attention.



Subcategory: Medical Equipment, Monitoring

Therapeutic Area(s): General Health



Technology

EarlySense's technology is based on advanced signal-processing algorithms developed and refined over years of extensive in-vivo testing. The patented systems include ultra-sensitive components that monitor patients without direct contact or the need for patient compliance. The algorithms enable clinically accurate tracking and measurement of respiration and heart rates, as well as patient movement, including bed entry/exit and patient turn verification as indicated by a nurse interface. Automatic System Operation EarlySense’s technology has three main components: 1) a unique single plate sensing unit; 2) a bedside unit that processes and displays the measured data; and 3) a central station display that enables complete coverage of a unit wide set of monitors at a single point and enables an interface to the nurses’ mobile devices. Once placed under a bed mattress, the sensing unit immediately self-activates whenever the patient is in bed. The continuously filtered, sampled and analyzed data can be stored, and if desired can be printed for documentation and clinician analysis. The system is FDA and CE cleared and has been shown to improve clinical outcomes in general care units.

Goal

Objectives: To be a market leader in the Medical Supervision Field

Target Businesses: Sales in USA, major clinical study at Harvard/leading university

Target Countries: USA, the Netherlands, Italy and Germany

20

Elitr Advanced Systems Ltd. Back to TOC

www.elitr.com

Company at a Glance

Elitr Advanced Systems Ltd. is a medical device company founded in Israel in 2005. The company’s mission is to offer a full range of non-invasive, multi-parameter patient monitoring devices and health management software tools to the full satisfaction of its customers and end-users. Elitr stations can be used for preventive screening for emergency room of national hospitals Elitr develops and manufactures distinct and innovative products hardware and software. The company's unique approach encourages the adoption of a preventative medicine and healthy lifestyle by simplifying the diagnosis and implementation processes by health stations, both of the individual and for the accompanying professionals.



Subcategory: Diagnostic, Monitoring, Telemedicine, SW & HW, Biometrics

Therapeutic Area(s): Primary Care, General Health, Cardiovascular, Diabetics, Obesity



Elitr provides: health station, specially designed to meet the needs of individuals and organizations that either wish to cut down their costs (e.g. hospitals and retirement homes), to increase their profits (e.g. pharmacy chains and gyms), or to improve their health and nutrition management. The health station provides gold standard measurement of some or all of the following vital signs: height, weight, BMI (Body Mass Index), RMR (Resting Metabolic Rate), hand grip strength test, body composition, blood pressure, pulse rate, electrical activity of the heart (EKG), heart rhythm regularity oxygen saturation, body temperature – all through a quick, non-invasive, single-posture process. In addition, they can be complemented by external monitoring devices. Elitr’s health station are automatically subscribed to the complementary health and weight management software BioFat, and can be subscribed to any other external database, including electronic medical records (EMRs). Telehealth MultiNurse, Elitr's most advanced health station model, also includes video conferencing and other telecommunications features, and it can also be compatible with the medical magnetic or smart card.

Goal

Objectives: To establish a worldwide distribution network, joint ventures with customers or distributors of diagnostic devices, health insurance companies

Target Businesses: Hospitals, private clinics, medical devices distributors, health spa channels, pharmacies

Target Countries: Europe, Asia, North Africa, Middle East

21

Elmedical Ltd. Back to TOC

www.elmedical.co.il

Company at a Glance

Elmedical offers practical and better solutions for two unmet urological diseases: non-muscle invasive bladder cancer (NMIBC) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). In both diseases, other emerging thermal treatments already showed proof of concept and resulted in multiple procedures for each patient over the years. NMIBC and CP/CPPS are treated successfully by the company's office-based system (compact console and disposable catheters), which is approved in Europe and Israel as a urological thermal treatment platform. Elmedical's innovative solutions in these diseases offer superior clinical results and better economics. In the future, the company's platform plans to cover two more unmet urological diseases: overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS). In addition, Elmedical is aiming for its "hot urology solutions" to become the market preferred solutions in the four unmet diseases.



Subcategory: Minimally Invasive Systems

Therapeutic Area(s): Urology, Gynecology, Oncology



Elmedical's proprietary non-ablative high temperature innovative technologies UniThermia and DuoThermia, covered by issued and pending patents, have clear and unique advantages over the other emerging thermal treatments in NMIBC and CP/CPPS. The company's BWT (Bladder Wall Thermochemotherapy) treats NMIBC with uniform hyperthermia (UniThermia) all over the bladder with a high flow of a heated chemotherapy solution. The BWT powerful heat-chemotherapy synergy is very effective and has practically no adverse events. DuoThermia provides simultaneous thermal treatments to the prostate (by a heated balloon) and bladder (by a heated saline circulation) to treat CP/CPPS where it prevails, the prostate and bladder, with dedicated heat sources and the other pelvic organs with the heated blood perfusion.

Goal

Objectives: To find a strategic partner and/or national distributors, established in urology, to market and sell the company's unique technology worldwide

Target Businesses: Cooperation with a strategic partner/distributors to develop the market in the unmet urological diseases and to support the clinical and regulatory processes in various countries

Target Countries: Europe, South America, Asia and the US

22

ElsMed Medical Systems Ltd. Back to TOC

www.elsmed.com Company at a Glance

ElsMed is a worldwide medical equipment supplier with extensive experience and known for high quality, fully refurbished diagnostic imaging medical equipment at an affordable price point. We have built our reputation for being the most trusted professional source for top quality and reliable equipment, service, parts and technical support.



Subcategory: Diagnostic, Imaging, Training, Medical Equipment

Therapeutic Area(s): General Health



Our capabilities range from providing completely refurbished medical equipment, supplying all spare parts and ongoing service with extremely fast response time and On-Line Remote-Diagnostic support in real time. Our services range from initial consultation and evaluation, to complete turn-key projects for all diagnostic imaging centers and hospitals. Our staff includes the most experienced field engineers and factory trained support specialists for CT, MRI, NM, PET, Ultrasound and other technologically advanced systems. We service and support over 150 systems worldwide. ElsMed will be your first partner in providing low-cost, high-end medical equipment and service to any imaging diagnostic centers worldwide. Products: • Computer Tomography Systems • Nuclear Medicine Systems • MRI • ULS • NM Diagnostic Workstation • CT Diagnostic Workstation

Goal

Objectives: Looking for dealers of refurbished medical equipment and turn-key projects for medical venters

Target Businesses: Medical Imaging


23

Erika Carmel Ltd. Back to TOC

www.gd-energies.com

Company at a Glance

As a company whose goal is to bring innovations in treatment, care, and quality of life to more and more people, we are proud to present you with cutting edge technology in soft laser therapy: B-Cure Laser is the world's first portable soft laser medical device WITH THE HEALING POWER OF A CLINIC.

B-CURE Laser is recommended by the best pain specialists and is used widely in Israel by the leading pain clinics, wound healing clinics, and orthopedic departments in the following hospitals: Hadassah-Jerusalem, Sourasky, Rambam, and Sheba (Tel Hashomer). It is also used by the physiotherapy clinics of Israel Defense Force, leading sports clubs, and the best sportsmen in Israel, as well as by thousands of individuals for self-treatments at home. On January 2010 B-Cure Laser received the European CE 0120 approval for 16 indications and is presently being exported to some European countries. CE 0120 approved indications of B-Cure Laser are: knee pain, pain in neck, lower and upper back, sports injuries, muscle pain, arthritis, fibromyalgia, tennis elbow, Achilles tendonitis, carpal tunnel syndrome, inflammation, wound healing, burns, fresh surgical scars, post-pregnancy stretch marks, acne, herpes simplex, dental medicine, acupuncture.




Therapeutic Area(s): Orthopedic, Wound and Pain Management, Dermatology, Rehabilitation



B-Cure Laser- LLLT 808- Low Level Laser Treatment The soft-laser effects the skin’s surface and simultaneously penetrates the skin without heating or hurting the skin. Soft laser treatment biostimulates the body’s natural healing mechanisms on a cellular and systemic level. The result: each kind of cell receives the energy required for activation of its optimal functioning in the body, thus allowing it to “self-heal” and naturally overcome specific problems. B-CURE LASER - an international breakthrough in soft laser therapy for professional and personal treatment of the aforesaid indications. Thanks to an exclusive, patent-pending development, we have created an exceptional combination: the power and full coherence of a clinic's soft laser device over a large area of 4.5 cm², with a portable, rechargeable, safe and easy-to-use device – all at a reasonable price. The result: a perfect combination of the most effective therapy with the ability to provide immediate and continuous treatments, thus enabling high quality and fast recovery in shorter individual treatment times, and with less total healing time.

Goal

Objectives: Distribution

Target Businesses: Clinics, hospitals, sports teams, athletes, security forces, home care, nursing homes, and individuals for self-treatment at home.

Target Countries: EU, USA, South America, Australia

24

ETView Back to TOC

www.etview.com

Company at a Glance

ETView manufactures the Tracheoscopic Ventilation Tube (TVT), an endotracheal tube fitted with a camera and light source for continuous monitoring of the airways.

The TVT is the ideal tube for airway management, as it reduces the occurrences of difficult intubation while providing hospitals with a 100% verification of tube location and pinpointed suctioning of secretion buildup. By allowing for continous viewing of the airway, the TVT can minimize the amount of patient X-rays and should significantly reduce instance of VAP.

The TVT is also sold as a trainer, and is the ideal device for teaching and refreshing intubation skills to medical students and emergency personnel.



Subcategory: Disposable

Therapeutic Area(s): Emergency Medicine, General Surgery, Intensive Care, Respiratory



ETView’s patented, single-use tracheoscopic ventilation tube (TVT) incorporates a video camera and light source embedded in the tip of a conventional ventilation tube. The images from the TVT can be viewed on ETView's dedicated monitors, or on other monitors/computers.

With a camera at this critical location, medical personnel can effectively monitor, identify, and perform suction on the buildup of secretions in both lungs, thereby significantly minimizing the risk of ventilator-associated pneumonia.

The TVT is indicated for use in the ICU, OR, ER and pre-hospital.

Goal

Objectives: To find distributors that will sell the TVT in their respective markets



25

First Care Products Back to TOC

www.firstcareproducts.com

Company at a Glance

First Care Products specializes in the development and marketing of new products for pre-hospital emergency medical situations. The company's mission is to provide intelligent, innovative, effective and simple to use products which assist in life-saving, improve the treatment provided and yield significant savings in time and resources. Save One Life, Save A World

Active in medical R&D, the company develops beneficial solutions for pre-hospital medical emergencies. First Care Products provides medics, first responders and the injured themselves with easy and quick to use, effective products for the control of hemmorhage resulting from trauma that save lives and greatly boost the treatment provided, whether on the battlefield, home front or accident scene. The company brings its years of comprehensive R&D and field experience to create products that, when every second counts, make the difference between life and tragedy.



Subcategory: Disposables

Therapeutic Area(s): Emergency Medicine



The Emergency Bandage First Care Products' first and flagship product, The Emergency Bandage in all its versions has been designated as the "STANDARD" Personal Field Dressing by numerous major, quality military organizations, and is used by Special Forces and military medical corps worldwide. The Emergency Bandage is combat and clinically proven, being relied upon as an integral and vital component in the treatment of hemorrhage and trauma-related injuries. Beyond Military Use In addition to militaries around the world, First Care Products supplies its innovative bandages to governmental and private emergency medical services, Fire and Rescue, Police and Prison Authorities, First Aid and Survival Academies, and suppliers of first aid equipment to the general public. Worldwide Patent and Approvals First Care Products' bandages are patented worldwide, FDA and CE Approved, with health ministry approvals in each territory, NATO Reference Numbers, and NSNs in the USA. First Care Products manufactures all its products according to the highest International standards, including ISO 13485.

Goal

Objectives: Strategic Alliances

Target Businesses:


26

Flexicath Back to TOC

www.flexicath.com

Company at a Glance

Flexicath developed and market breakthrough catheter insertion systems to ensure simple, safe, and sterile intravenous catheterization. Addressing the need for a safe, easy-to-insert catheter for up to a 29-day treatment period, Flexicath has developed the M/29, a technology that combines a 30-day indweller IV catheter with special designed OTN introducers and an innovative 360 maximum barrier self-enclosed design to allow completely sterile insertion systems that are: • Safer and reduce risk of contact or airborne infections • Easier to use • More cost-effective, and do not require an external sterile environment



Subcategory: Disposable, Implantable

Therapeutic Area(s): Hematology, Intensive Care, Internal Medicine, Oncology, Orthopedic, Pediatrics, Peripheral Vascular



The M/29 combines a standard PICC line-type catheter that is completely enclosed in a sterile silicon sleeve and PeelGuard™, a special silicone insertion unit. The sleeve creates a self-contained, sterile insertion field to form a 3D 360 maximum barrier. This design has several advantages: • Throughout the insertion procedure the catheter is fully encased and prevents touch and airborne

contamination. • The system virtually eliminates blood backflow. • The insertion procedure is safe, simple, can be done by a floor nurse and is cost effective. • The M/29 has IV dwell time of up to 29 days

Goal

Objectives: Distribution, Alliances

Target Businesses: Industry leaders, manufacturers

Target Countries: Germany, France, UK, Italy, Spain, South Africa, Australia

27

Flight Medical Back to TOC

www.flight-medical.com

Company at a Glance

Established in 1996, Flight Medical specializes in the development, manufacturing and marketing of respiratory life supporting equipment. Since its inception, Flight Medical had been focused on the high end of the portable ventilators market. Flight Medical develops and manufactures the HT50 (marketed worldwide exclusively by Newport Medical Instruments, Inc.), and its newly introduced Flight 60, both incorporating Flight Medical’s proprietary technology. To date over 12,000 Flight Medical ventilators have been helping patients worldwide, winning their reputation as a truly reliable, feature-loaded yet easy and intuitive to use portable ventilator. Flight Medical is a public company listed on the Tel Aviv Stock Exchange, with offices located in Lod, Israel. Flight Medical is a subsidiary of Medtechnica, Israel’s largest distributor of medical equipment.




Therapeutic Area(s): Emergency Medicine, Intensive Care, Primary Care, Pulmonary, Rehabilitation, Respiratory



Flight Medical, the developer and manufacturer of the HT50 ventilator, which has been successfully used in a broad range of applications for over 10 years, is now offering an opportunity to participate in the launch of its new Flight 60 ventilator. Designed to continue the success of the 12,000 Flight Medical HT50 ventilators operating mainly in the United States and Japan, the newly introduced Flight 60 Ventilator offers even more: • Improved ventilation modes • Exhalation volume measurement • An intuitive 7" touch screen interface • 12 hours of battery life. Hot Swap capability provides practically unlimited independence • External communications The Flight 60 ventilator is a perfect fit for Home Care, Long Term Care, Transport and Hospitals

Goal

Objectives: Establish distribution network for our Flight 60 ventilator throughout the world.

Target Businesses: Distributors of medical devices, calling on Home Care, Long Term Care, Transport and Hospitals.


28

Haldor Advanced Technologies Ltd. Back to TOC

www.haldor-tech.com

Company at a Glance

Haldor Advanced Technologies Ltd. specializes in integrating technological solutions that meet the business needs of the healthcare industry. The company was founded with a declared purpose to enhance surgical procedures with safe and efficient technological systems that will benefit doctors, surgeons, hospitals and, most importantly, patients.


Category: Medical Devices Subcategory: Medical Equipment Therapeutic Area(s): General Surgery Company Status: Initial Revenues


ORLocate™ is an RFID-based system that counts, monitors, and tracks surgical instruments and sponges. ORLocate™ was designed to change the way Operating Rooms around the world perform counts and manage their assets. It is the first RFID technology system of its kind that offers an all-encompassing solution with automated counting and advanced tracking features that significantly enhance patient safety and maximize overall productivity and yield of hospitals, doctors and nurses. Human-related errors are attributed to faulty counting systems and negligible tracking procedures that are costing the United States healthcare industry over $2 billion annually. ORLocate™ offers hospitals a business opportunity to tap into long-term revenue schemes with a high Return on Investment while focusing on the highest industry standards for patient safety.

Goal

Objectives: Seeking strategic marketing partner in Europe and Southeast Asia

Target Businesses: Target Countries: EMEA and SEA

29

Hanita Lenses Back to TOC

www.hanitalenses.com

Company at a Glance

Established in 1981, Hanita Lenses is Israel's market leader and foremost manufacturer of Intraocular Lenses and Contact Lenses, with more than 60% of the local market. Hanita’s strategy focuses on innovation in R&D and technology, in order to maintain the company as a dynamic leading player in the ophthalmic medical device market. Hanita’s products are sold through a network of distributors throughout Europe, Asia, Latin America, and elsewhere. Lenses manufactured by Hanita Lenses meet the highest quality standard required by the European Union and carry the mark of approval: • European CE Mark • ISO 13485:2003 Medical Device Quality System • ISO 9001: 2000 Quality Systems



Subcategory: Disposable, Implantable

Therapeutic Area(s): Ophthalmology



Intraocular Lenses:

Investments in stage-of-the-art equipment and technology, both in R&D and production, have placed Hanita in a leading position, enabling the company to compete in the fast-changing IOL market. New, advanced products are continually in the R&D pipeline. Hanita’s highly skilled team works in close collaboration with the company’s advisory board, comprising leading ophthalmic surgeons, and led by Prof. Ehud Asia. This collaboration allows the company to develop innovative intraocular lense designs that support new surgical techniques. Contact Lenses:

Hanita Lenses manufactures and sells a broad range of GP, soft, conventional, special and disposable contact lenses, using the most advanced raw materials. Special designs, such as Toric Lenses, Keratoconus, Orthokeratology and lenses for dry eyes, are included in the range. The latest computerized techniques, as well as the state-of-the-art equipment, contribute to the excellence of our contact lens division.

Goal

Objectives: Finding sutable distributors for Hanita Lenses products

Target Businesses: Opthalmic market, specifically the cataract field

Target Countries: Europe - UK, Germany, Ireland, the Netherlands, Belgium, Spain, Scandinavia, Eastern Europe, Turkey, South Korea and Asia-Pacific

30

HypnoCore Ltd. Back to TOC

www.hypnocore.com

Company at a Glance

HypnoCore Ltd. was founded in 2006 with the vision of developing new methods to detect sleep disorders. The company was formed following over 10 years of successful academic collaboration between the founders, resulting in a technological breakthrough that has become the company's core technology. Mission Statement: HypnoCore is an innovative leader in the wellness and healthcare industries, and has revolutionized the field of sleep medicine by providing reliable, cost effective and user friendly sleep diagnostic solutions for home use that will help facilitate the treatment of chronic conditions and elevate the general quality of life. Medical Market Status: • CE, FDA approvals in 2008 • Medical market services launched in Germany and Israel in 2010 • Patent approved • Cooperation with leading Israeli corporate wellness companies • Consumer Business Status:•Full integration underway with Polar and Suunto heart rate monitors • Cooperation with Suunto in the wellness market • Research cooperation with Polar • Cooperation with the Wingate Institute - Israel's leading sports institution



Subcategory: Diagnostic, Monitoring, Telemedicine, Research Equipment, Training, SW & HW

Therapeutic Area(s): Cardiovascular, Dental, Ear, Nose and Throat, General Health, Obesity, Primary Care, Respiratory

Company Status: Regulatory Approval


In the medical market, HypnoCore technology enables the convenient collection of ECG data in people's homes and provides sleep laboratories with the opportunity for unlimited virtual expansion. With HypnoCore’s solutions, sleep laboratories and medical practitioners can expand their patient load to include multiple out-patients who simply send and receive their results and diagnosis over the web at a fraction of the cost of conventional in-patient procedures. The upgrade in the entire process will enable medical institutions to expand their patient populations without incurring major expenses. In the wellness and consumer healthcare market, HypnoCore technology will allow the average person to evaluate and improve his sleep on his own. In the initial stages, HypnoCore will offer a web application for sleep analysis and a guide on how to improve sleep, for heart rate monitor users of the most popular brands such as Polar, Suunto, Garmin, and others. These users are generally sportsmen, athletes and people independently seeking solutions or striving to improve their health and wellness.

Goal

Objectives: Strategic Alliances

Target Businesses:


31

Intromedix Back to TOC

www.intromedix.com

Company at a Glance

Intromedix is an Israeli manufacturer of premium quality, cost-effective, generic, disposable surgical equipment.



Subcategory: Disposable, Implantable, Medical Equipment

Therapeutic Area(s): General Surgery



Surgical Sutures - absorbable and non-absorbable Surgical Staplers Skin Staplers Surgical Mesh

Goal

Objectives: Establish partnerships for distributing our products in key European countries.


Target Countries: All European countries

32

Itamar Medical Back to TOC

www.Itamar-Medical.com

Company at a Glance

Itamar Medical Ltd. is a public traded (TASE: ITMR) bio-medical technology company. Itamar develops and markets noninvasive diagnostic medical equipment based on the proprietary PAT™ (Peripheral Arterial Tone) Signal. The PAT™ Signal serves as a noninvasive window to the Cardiovascular and Autonomic Nervous Systems. The PAT Signal is acquired by measuring pulsatile arterial volume changes in the fingertip by specialized noninvasive probes. Itamar’s FDA cleared and CE marked PAT-based products include: • Endo-PAT2000: noninvasive, office-based, user-independent device for endothelial function

assessment – the precursor (earliest clinically detectable stage) of cardiovascular disease. • Watch-PAT200: ambulatory diagnosis of sleep-related breathing disorders and sleep staging

(Wake/REM/Deep Sleep/Light Sleep stages).

Both devices are used in preeminent clinical institutions, research centers and pharmaceutical clinical phase studies in over 40 countries, which have yielded nearly 300 publications.




Therapeutic Area(s): Cardiovascular, Dental, Ear Nose and Throat (ENT), General Health, Internal Medicine, Neurology and Degenerative Disease, Peripheral Vascular, Primary Care, Respiratory



Sleep testing - at home Considered “best in class,” WatchPAT (FDA cleared and CE marked) is a wrist mounted device for at-home testing of sleep apneas and sleep staging (REM/Deep Sleep/Light Sleep/Wake stages). WatchPAT also measures snoring & body position and provides a perfect combination of natural sleep at home with sleep-lab level data. WatchPAT works without the multiple cables and electrodes needed by other technologies that provide in-depth analysis of sleep, so it has an incredibly low failure rate. Yet the physician gets a comprehensive report with all the clinical parameters needed for patient treatment and monitoring. While the data are calculated automatically by the WatchPAT’s software, the physician can easily edit the data as well.

Noninvasive cardiovascular risk assessment

Atherosclerosis is the clinical manifestation of endothelial dysfunction. Leading the field of endothelial function assessment, EndoPAT (FDA cleared and CE marked) is used in pre-eminent clinical institutions, research centers and Pharma studies. The noninvasive EndoPAT has been validated by nearly 100 publications and abstracts, and it provides clinicians with reliable and reproducible results in a 15-minute, office-based test.

Goal

Objectives: Establish wide distribution network in Europe Target Businesses: Distribution Target Countries: Brazil, Germany, UK, Spain, France

33

Medical Market Bridge Ltd. Back to TOC

www.mmbim.com

Company at a Glance

Medical Market Bridge (MMB) is an international marketing and business development company that acts as a bridge for medical device companies and rapidly brings innovative technologies to market success. MMB is actively present in a vast range of international medical device markets. MMB specializes in creating and managing revenue making sales channels for medical device companies. Each member of our group of 13 medical device experts is situated in his home country, where he has the experience and contacts to enable smooth market entry. MMB covers Europe, Pacific and Latin America. What do we do for our clients? For each manufacturing client, we match the best suited distributor, from a database of thousands. This important stage in the commercial lifecycle is done according to marketing strategy and local market characteristics. We strive to achieve a solid distribution agreement and manage the commercial interaction between the parties, being the manufacturer marketing office in each country. Low risk unique compensation model - MMB fees are success dependent. This means that our clients pay us only once real commercial activity has started.


Category: Services

Subcategory: Business Development




MMB at Medica – B2B Our open booth at Medica will host B2B meetings, where manufacturers and distributors will discuss business collaboration. This is a great opportunity for creating new business partnerships. We invite manufacturers to participate in our B2B program, and make Medica an effective event. Distributors are also invited to contact us and see what we can offer to add to their product line. MMB represents several innovative technologies seeking distribution partners from Europe, Asia- Pacific region and Latin America. We are always glad to meet distribution companies and present our technologies to them. Currently, we offer technologies in Surgery, Urology, Gynecology, Orthopedics, Pain Management, Oncology, Anesthesia, Cardiology, Vascular Aurgery and more.

Goal

Objectives: MMB creates face to face meetings between manufacturers and distributors, and represents our current technologies

Target Businesses: Manufacturers and distributors of medical devices


34

MediTouch Back to TOC

www.meditouch.co.il

Company at a Glance

MediTouch manufactures and sells innovative upper and lower limb active exercise systems with biofeedback trainers. The rehabiliation systems consist of gloves, elbow and leg braces, as well as dedicated rehabilitation software. The systems are designed to help patients recovering from stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and incomplete spinal cord injury regain hand and leg movement.



Subcategory: Medical Equipment, Telemedicine, Training

Therapeutic Area(s): Cardiovascular, Neurology and Degenerative Disease, Pediatrics, Orthopedic, Primary Care, Rehabilitation



HandTutor, ElbowTutor, LegTutor, AnkleTutor

Goal

Objectives: Looking to establish a wide distribution network



35

Medoc Ltd. Back to TOC

www.medoc-web.com

Company at a Glance

Medoc is a leading manufacturer of neuro-diagnostic medical systems and advanced thermal stimulators for the assessment of chronic pain. Medoc's products evaluate the small and large peripheral sensory nerve fibers (A-delta and C fibers), constituting the "Pain Pathway." In 2006, Medoc established the Medoc Israel Division. This division represents companies worldwide, promoting and distributing their advanced medical solutions to the Israeli market. Medoc Ltd. has developed several strategic collaborations with leading international suppliers from the USA and Europe, including Boston Scientific, for treating severe and chronic pain patients by implanting advanced spinal cord stimulation (SCS) device, Neurotherm for treatment of local pain by applying Radio Frequency (RF) directly to the pain source, Epimed for nerve block solutions and catheters and HydroCision for minimal invasive discectomy.




Therapeutic Area(s): Neurology and Degenerative Disease, Pain Management



The PATHWAY Pain and Sensory Evaluation System offers new applications for advanced pain research and fMRI. The PATHWAY model CHEPS (Contact Heat-Evoked Potential Stimulator) marks a breakthrough in the field of pain-evoked potential, allowing objective assessment of evoked pain. The PATHWAY model ATS (Advanced Thermal Stimulator) and PATHWAY model CHEPS are currently used in fMRI studies and in advanced pain research. The TSA-II Thermal Sensory Analyzer is used in QST (Quantitative Sensory Testing) to clinically evaluate small nerve fibers (A-delta and C fibers). The VSA-3000 Vibratory Sensory Analyzer is used in the assessment of large peripheral nerve fibers (A-beta). The recently launched Computerized Algometer is a new software-based system, providing real-time visual and auditory feedback to control and monitor applied pressure rates. Medoc is also interested in expanding its scope of products in the Israeli market by signing partnership agreements with promising medical device companies offering breakthrough technology a

Documents

Medica Companies Portfolio20 · MEDICA 2010 Israel inspired by innovation The Israel Export & International Cooperation Institute. 2 Israel: Life Science Powerhouse Israeli physicians,